ArticleMolecular horticulture2026
DIMORPH: an integrated multi-omics resource for camptothecin-producing plants.
Article in Molecular horticulture, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
Abstract
Over the past decade, extensive multi-omics data of camptothecin (CPT)-producing plants have been generated, resulting in a wealth of genomic resources. However, to date, no available database supports utilization for understanding biological mechanisms of CPT biosynthesis. In this study, we constructed DIMORPH ( https://www.dimorph.cn:9000 .), a Database Integrated Multiple Omics Resources for CPT-Producing Herbs. The database consolidated genomic, transcriptomic, and metabolic data of the three representative CPT-producing plants including Camptotheca acuminata, Ophiorrhiza pumila and Nothapodytes nimmoniana, and integrated functional annotation, synteny, and co-expression analytical results. Utilizing DIMORPH, a new CPT 10-hydroxylase (CPT10H), CYP81BQ24, was identified in C. acuminata. Structural comparison between CYP81BQ24 and CYP81BQ23 (CPT 11 hydroxylase), combined with fragment substitution mutagenesis, revealed ten key amino acid residues determined the regio-selectivity of CPT hydroxylases (CPTHs) at C-10 and C-11 position. Additionally, a high-efficiency CPT10H mutant was obtained through site-directed mutagenesis guided by sequence alignment and structural prediction of 17 CYP450 hydroxylases. Therefore, the comprehensive database focused on CPT will be helpful to the elucidation of CPT biosynthetic pathway and production of CPT-derived drugs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.